Skip to main content
SpringerLink
Log in

High-Intensity Focused Ultrasound

  • Chapter
  • First Online:
Imaging and Focal Therapy of Early Prostate Cancer

Part of the book series: Current Clinical Urology ((CCU))

Abstract

High-intensity focused ultrasound (HIFU) is an effective noninvasive procedure for the focal treatment of prostate cancer (PCa). The possibility of inducing precise coagulative necrosis of the tumor with sharp boundaries makes HIFU one of the best options for focal therapy. Ablation of the tissue is achieved by the application of high-intensity ultrasound waves focused on a fixed focal point, resulting in maximum pressure converted into heat, thus inducing thermal ablation of the targeted area without affecting the surrounding tissues. Different devices are available for HIFU therapy, all allowing the precise localization and treatment of the cancerous area via a transrectal approach. The feasibility of focal HIFU for primary treatment of low- to intermediate-risk PCa patients was demonstrated in several studies reporting short- to midterm follow-up. Published data show satisfactory oncologic outcomes, with low rates of disease recurrence and progression. As a noninvasive modality, focal HIFU led to excellent functional results in terms of both urinary continence and erectile function recovery rates, with a low overall morbidity rate. Encouraging results have also been reported in the setting of focal salvage treatment of recurrent PCa after either radiotherapy or brachytherapy. Focal HIFU should be considered an effective option for selected patients with clinically significant localized PCa.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Haar GT, Coussios C. High intensity focused ultrasound: physical principles and devices. Int J Hyperth. 2007;23(2):89–104.

    Article  Google Scholar 

  2. Gelet A, Chapelon JY, Margonari J, Theillere Y, Gorry F, Cathignol D, et al. Prostatic tissue destruction by high-intensity focused ultrasound: experimentation on canine prostate. J Endourol. 1993;7(3):249–53.

    Article  CAS  PubMed  Google Scholar 

  3. Crouzet S, Lafond C, Chapelon JY, Gelet A. Focal high-intensity focused ultrasound (hifu). In: Barret EDM, editor. Technical aspects of focal therapy in localized prostate cancer. Paris: Springer; 2014. p. 137–51.

    Google Scholar 

  4. Chaussy CG, Thuroff S. Robot-assisted high-intensity focused ultrasound in focal therapy of prostate cancer. J Endourol. 2010;24(5):843–7.

    Article  PubMed  Google Scholar 

  5. Rouviere O, Glas L, Girouin N, Mege-Lechevallier F, Gelet A, Dantony E, et al. Prostate cancer ablation with transrectal high-intensity focused ultrasound: assessment of tissue destruction with contrast-enhanced us. Radiology. 2011;259(2):583–91.

    Article  PubMed  Google Scholar 

  6. Schneider M. Sonovue, a new ultrasound contrast agent. Eur Radiol. 1999;9(Suppl 3):S347–8.

    Article  PubMed  Google Scholar 

  7. Kirkham AP, Emberton M, Hoh IM, Illing RO, Freeman AA, Allen C. MR imaging of prostate after treatment with high-intensity focused ultrasound. Radiology. 2008;246(3):833–44.

    Article  PubMed  Google Scholar 

  8. Rouviere O, Lyonnet D, Raudrant A, Colin-Pangaud C, Chapelon JY, Bouvier R, et al. MRI appearance of prostate following transrectal hifu ablation of localized cancer. Eur Urol. 2001;40(3):265–74.

    Article  CAS  PubMed  Google Scholar 

  9. Illing RO, Kennedy JE, Wu F, ter Haar GR, Protheroe AS, Friend PJ, et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a western population. Br J Cancer. 2005;93(8):890–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ganzer R, Rogenhofer S, Walter B, Lunz JC, Schostak M, Wieland WF, et al. Psa nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer. Eur Urol. 2008;53(3):547–53.

    Article  CAS  PubMed  Google Scholar 

  11. Roach 3rd M, Hanks G, Thames Jr H, Schellhammer P, Shipley WU, Sokol GH, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-astro phoenix consensus conference. Int J Radiat Oncol Biol Phys. 2006;65(4):965–74.

    Article  PubMed  Google Scholar 

  12. Blana A, Brown SC, Chaussy C, Conti GN, Eastham JA, Ganzer R, et al. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure. BJU Int. 2009;104(8):1058–62.

    Article  CAS  PubMed  Google Scholar 

  13. Uchida T, Illing RO, Cathcart PJ, Emberton M. To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate? BJU Int. 2006;98(3):537–9.

    Article  CAS  PubMed  Google Scholar 

  14. Ganzer R, Robertson CN, Ward JF, Brown SC, Conti GN, Murat FJ, et al. Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the stuttgart failure criteria – analysis from the @-registry. BJU Int. 2011;108(8 Pt 2):E196–201.

    Article  PubMed  Google Scholar 

  15. Muller BG, van den Bos W, Brausi M, Futterer JJ, Ghai S, Pinto PA, et al. Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project. World J Urol. 2015;33(10):1503–9.

    Article  CAS  PubMed  Google Scholar 

  16. Delongchamps NB, Haas GP. Saturation biopsies for prostate cancer: current uses and future prospects. Nat Rev Urol. 2009;6(12):645–52.

    Article  PubMed  Google Scholar 

  17. Biermann K, Montironi R, Lopez-Beltran A, Zhang S, Cheng L. Histopathological findings after treatment of prostate cancer using high-intensity focused ultrasound (HIFU). Prostate. 2010;70(11):1196–200.

    Article  PubMed  Google Scholar 

  18. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. Eau guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol. 2014;65(2):467–79.

    Article  CAS  PubMed  Google Scholar 

  19. Valerio M, Ahmed HU, Emberton M. Focal therapy of prostate cancer using irreversible electroporation. Tech Vasc Interv Radiol. 2015;18(3):147–52.

    Article  PubMed  Google Scholar 

  20. Sivaraman A, Barret E. Focal therapy for prostate cancer: an “a la carte” approach. Eur Urol. 2016;69(6):973–5.

    Google Scholar 

  21. Boutier R, Girouin N, Cheikh AB, Belot A, Rabilloud M, Gelet A, et al. Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer. BJU Int. 2011;108(11):1776–81.

    Article  PubMed  Google Scholar 

  22. Beerlage HP, van Leenders GJ, Oosterhof GO, Witjes JA, Ruijter ET, van de Kaa CA, et al. High-intensity focused ultrasound (hifu) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective study. Prostate. 1999;39(1):41–6.

    Article  CAS  PubMed  Google Scholar 

  23. Uchida T, Nakano M, Hongo S, Shoji S, Nagata Y, Satoh T, et al. High-intensity focused ultrasound therapy for prostate cancer. Int J Urol. 2012;19(3):187–201.

    Article  PubMed  Google Scholar 

  24. Ahmed HU, Cathcart P, McCartan N, Kirkham A, Allen C, Freeman A, et al. Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy: a pilot study. Cancer. 2012;118(17):4148–55.

    Article  PubMed  Google Scholar 

  25. Baco E, Gelet A, Crouzet S, Rud E, Rouviere O, Tonoli-Catez H, et al. Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study. BJU Int. 2014;114(4):532–40.

    Article  PubMed  Google Scholar 

  26. Kanthabalan A, Arya M, Punwani S, Freeman A, Haroon A, Bomanji J, et al. Role of focal salvage ablative therapy in localised radiorecurrent prostate cancer. World J Urol. 2013;31(6):1361–8.

    Article  CAS  PubMed  Google Scholar 

  27. Leibovici D, Spiess PE, Heller L, Rodriguez-Bigas M, Chang G, Pisters LL. Salvage surgery for locally recurrent prostate cancer after radiation therapy: tricks of the trade. Urol Oncol. 2008;26(1):9–16.

    Article  PubMed  Google Scholar 

  28. Muto S, Yoshii T, Saito K, Kamiyama Y, Ide H, Horie S. Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol. 2008;38(3):192–9.

    Article  PubMed  Google Scholar 

  29. Ahmed HU, Freeman A, Kirkham A, Sahu M, Scott R, Allen C, et al. Focal therapy for localized prostate cancer: a phase I/II trial. J Urol. 2011;185(4):1246–54.

    Article  CAS  PubMed  Google Scholar 

  30. El Fegoun AB, Barret E, Prapotnich D, Soon S, Cathelineau X, Rozet F, et al. Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly. A feasibility study with 10 years follow-up. Int Braz J Urol. 2011;37(2):213–9. discussion 220-212

    PubMed  Google Scholar 

  31. Ahmed HU, Hindley RG, Dickinson L, Freeman A, Kirkham AP, Sahu M, et al. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol. 2012;13(6):622–32.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Feijoo ER, Sivaraman A, Barret E, Sanchez-Salas R, Galiano M, Rozet F, et al. Focal high-intensity focused ultrasound targeted hemiablation for unilateral prostate cancer: a prospective evaluation of oncologic and functional outcomes. Eur Urol. 2016;69(2):214–20.

    Article  PubMed  Google Scholar 

  33. Ahmed HU, Dickinson L, Charman S, Weir S, McCartan N, Hindley RG, et al. Focal ablation targeted to the index lesion in multifocal localised prostate cancer: a prospective development study. Eur Urol. 2015;68(6):927–36.

    Article  PubMed  Google Scholar 

  34. Asimakopoulos AD, Miano R, Virgili G, Vespasiani G, Finazzi AE. Hifu as salvage first-line treatment for palpable, trus-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study. Urol Oncol. 2012;30(5):577–83.

    Article  PubMed  Google Scholar 

  35. Kanthabalan A, Shah T, Arya M, Punwani S, Bomanji J, Haroon A, et al. The forecast study – focal recurrent assessment and salvage treatment for radiorecurrent prostate cancer. Contemp Clin Trials. 2015. doi:10.1016/j.cct.2015.07.004.

Download references

Author information

Authors and Affiliations

  1. Department of Urology, IRCCS Ospedale San Raffaele/Università Vita-Salute San Raffaele, Milan, Italy

    Paolo Capogrosso

  2. Department of Urology, Institut Montsouris, Paris-Descartes University, Paris, France

    Eric Barret

Authors
  1. Paolo Capogrosso
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric Barret
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eric Barret .

Editor information

Editors and Affiliations

  1. Department of Surgery, Duke Cancer Institute, Durham, North Carolina, USA

    Thomas J. Polascik

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Capogrosso, P., Barret, E. (2017). High-Intensity Focused Ultrasound. In: Polascik, T. (eds) Imaging and Focal Therapy of Early Prostate Cancer. Current Clinical Urology. Springer, Cham. https://doi.org/10.1007/978-3-319-49911-6_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-49911-6_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-49910-9

  • Online ISBN: 978-3-319-49911-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation